JACOBS LEVY EQUITY MANAGEMENT, INC - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 35 filers reported holding SURFACE ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q3 2019$104,000
-60.8%
73,402
-22.0%
0.00%
-75.0%
Q2 2019$265,000
-39.4%
94,100
+2.7%
0.00%
-33.3%
Q1 2019$437,000
+193.3%
91,600
+160.7%
0.01%
+100.0%
Q4 2018$149,000
+11.2%
35,134
+187.2%
0.00%
+50.0%
Q3 2018$134,00012,2340.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q4 2019
NameSharesValueWeighting ↓
Atlas Venture Associates XI, LLC 2,945,453$27,216,0004.31%
Atlas Venture Associates IX, LLC 2,945,453$27,216,0004.31%
ACUTA CAPITAL PARTNERS, LLC 999,500$9,235,0002.51%
COMMODORE CAPITAL LP 467,796$4,322,0002.35%
Ghost Tree Capital, LLC 1,000,000$9,240,0002.06%
VR Adviser, LLC 1,442,895$13,332,0001.96%
SILVERARC CAPITAL MANAGEMENT, LLC 130,000$1,201,0000.70%
Parkman Healthcare Partners LLC 175,792$1,624,0000.42%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 26,732$247,0000.39%
One68 Global Capital, LLC 15,071$139,0000.28%
View complete list of SURFACE ONCOLOGY INC shareholders